Search research articles
Contact Us
Filters
Showing results (171-180 of 201) with videos related to
Page
of 21
Sort By:
Nature Communications
|
January 17, 2025
TRIM28 is an essential regulator of three-dimensional chromatin state underpinning CD8<sup>+</sup> T cell activation
Kun Wei, Ruifeng Li, Xiaohong Zhao, et al.
Science (New York, N.Y.)
|
October 30, 2025
Glycolysis-compatible urethanases for polyurethane recycling
Yanchun Chen, Jinyuan Sun, Kelun Shi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 19, 2022
Multiomics Analysis Identifies SOCS1 as Restraining T Cell Activation and Preventing Graft-Versus-Host Disease
Huidong Guo, Ruifeng Li, Ming Wang, et al.
NPJ Digital Medicine
|
June 2, 2026
Mixed-methods study on GenAI Usage, dependence behaviors, and standardized application paths among Chinese medical students
Liujie Fu, Ruifeng Li, Wuxiang Shi, et al.
Science Advances
|
February 25, 2026
The conserved noncoding sequence CNS11 is a master control region for <i>Rorc</i> transcription in type 17 immune cells
Hao Zhang, Dehui Chang, Shiyuan Xie, et al.
The Journal of Experimental Medicine
|
January 23, 2023
STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection
Qinli Sun, Xiaohong Zhao, Ruifeng Li, et al.
Acta Pharmaceutica Sinica. B
|
March 30, 2026
PhenoModel: A multimodal phenotypic drug design foundation model for discovering novel potential inhibitors of multiple cancer cells
Shihang Wang, Qilei Han, Weichen Qin, et al.
Genes & Diseases
|
June 10, 2022
Salivary microbiota may predict the presence of esophageal squamous cell carcinoma
Junmin Wei, Ruifeng Li, Yanxian Lu, et al.
Cell Reports
|
June 1, 2024
NR4A1 transcriptionally regulates the differentiation of stem-like CD8<sup>+</sup> T cells in the tumor microenvironment
Jing Hao, Ruifeng Li, Xiaohong Zhao, et al.
British Journal of Clinical Pharmacology
|
August 18, 2016
Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximab
Jason H Williams, Matthew M Hutmacher, Matthew L Zierhut, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 201) with videos related to
Sort By:
Page
of 21
Nature Communications
|
January 17, 2025
TRIM28 is an essential regulator of three-dimensional chromatin state underpinning CD8<sup>+</sup> T cell activation
Kun Wei, Ruifeng Li, Xiaohong Zhao, et al.
Science (New York, N.Y.)
|
October 30, 2025
Glycolysis-compatible urethanases for polyurethane recycling
Yanchun Chen, Jinyuan Sun, Kelun Shi, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
May 19, 2022
Multiomics Analysis Identifies SOCS1 as Restraining T Cell Activation and Preventing Graft-Versus-Host Disease
Huidong Guo, Ruifeng Li, Ming Wang, et al.
NPJ Digital Medicine
|
June 2, 2026
Mixed-methods study on GenAI Usage, dependence behaviors, and standardized application paths among Chinese medical students
Liujie Fu, Ruifeng Li, Wuxiang Shi, et al.
Science Advances
|
February 25, 2026
The conserved noncoding sequence CNS11 is a master control region for <i>Rorc</i> transcription in type 17 immune cells
Hao Zhang, Dehui Chang, Shiyuan Xie, et al.
The Journal of Experimental Medicine
|
January 23, 2023
STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection
Qinli Sun, Xiaohong Zhao, Ruifeng Li, et al.
Acta Pharmaceutica Sinica. B
|
March 30, 2026
PhenoModel: A multimodal phenotypic drug design foundation model for discovering novel potential inhibitors of multiple cancer cells
Shihang Wang, Qilei Han, Weichen Qin, et al.
Genes & Diseases
|
June 10, 2022
Salivary microbiota may predict the presence of esophageal squamous cell carcinoma
Junmin Wei, Ruifeng Li, Yanxian Lu, et al.
Cell Reports
|
June 1, 2024
NR4A1 transcriptionally regulates the differentiation of stem-like CD8<sup>+</sup> T cells in the tumor microenvironment
Jing Hao, Ruifeng Li, Xiaohong Zhao, et al.
British Journal of Clinical Pharmacology
|
August 18, 2016
Comparative assessment of clinical response in patients with rheumatoid arthritis between PF-05280586, a proposed rituximab biosimilar, and rituximab
Jason H Williams, Matthew M Hutmacher, Matthew L Zierhut, et al.
Page
of 21